Achieve recognition of all radiotherapy professions
Lower GI Spotlight at ESTRO 2025: Trials, Trends, and Treatment Shifts
Ultra-hypofractionated Radiotherapy for Localised Prostate Cancer: 10-Year Outcomes of the HYPO-RT-PC Phase 3 Trial
Best paper award - Interdisciplinary: Advancing the ESTRO-HERO cost tool for innovative treatment costing and flexible resource allocation
The 17th European Multidisciplinary Congress on Urological Cancers (EMUC25)
CBCT vs. MR: Which will lead the future of online adaptive radiotherapy? Positioning & Immobilisation
Factors influencing locoregional recurrence rates in rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial